Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism
- PMID: 24458833
- DOI: 10.1007/s40618-014-0052-2
Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism
Abstract
Introduction and aim: The relationship between androgen receptor (AR) CAG polymorphism and bone metabolism is highly controversial. We, therefore, aimed to evaluate the independent role of AR CAG repeat polymorphism on bone metabolism improvement induced by testosterone replacement therapy (TRT) in male post-surgical hypogonadotropic hypogonadism, a condition frequently associated with hypopituitarism and in which the effects of TRT have to be distinguished from those resulting from concomitant administration of pituitary function replacing hormones.
Methods: 12 men affected by post-surgical hypogonadotropic hypogonadism [mean duration of hypogonadism 8.3 ± 2.05 (SD) months] were retrospectively assessed before and after TRT (from 74 to 84 weeks after the beginning of therapy). The following measures were studied: parameters of bone metabolism [serum markers and bone mineral density (BMD)], pituitary dependent hormones and genetic analysis (AR CAG repeat number).
Results: Total testosterone, estradiol, free T4 (FT4) and insulin-like growth factor-1 (IGF-1) increased between the two phases, while follicle stimulating hormone (FSH) decreased. While serum markers did not vary significantly between the two phases, BMD improved slightly but significantly in all the studied sites. The number of CAG triplets correlated negatively and significantly with all the variations (Δ-) of BMDs. Conversely, Δ-testosterone correlated positively and significantly with all studied Δ-BMDs, while Δ-FSH, Δ-estradiol, Δ-FT4, and Δ-IGF-1 did not correlate significantly with any of the Δ-BMDs. Multiple linear regression analysis, after correction for Δ-testosterone, showed that CAG repeat length was negatively and significantly associated with ∆-BMD of all measured sites.
Conclusions: Our data suggest that, in post-surgical male hypogonadotropic hypogonadism, shorter AR CAG tract is independently associated with greater TRT-induced improvement of BMD.
Similar articles
-
Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.J Sex Med. 2014 May;11(5):1302-8. doi: 10.1111/jsm.12493. Epub 2014 Mar 4. J Sex Med. 2014. PMID: 24593124
-
Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.Nutr Metab Cardiovasc Dis. 2014 Aug;24(8):908-13. doi: 10.1016/j.numecd.2014.02.016. Epub 2014 Mar 20. Nutr Metab Cardiovasc Dis. 2014. PMID: 24787905
-
Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.J Sex Med. 2015 Feb;12(2):381-8. doi: 10.1111/jsm.12790. Epub 2014 Dec 2. J Sex Med. 2015. PMID: 25443437
-
CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?J Sex Med. 2013 Oct;10(10):2373-81. doi: 10.1111/jsm.12268. Epub 2013 Jul 11. J Sex Med. 2013. PMID: 23844628 Review.
-
Pharmacogenetics of testosterone replacement therapy.Pharmacogenomics. 2009 Aug;10(8):1341-9. doi: 10.2217/pgs.09.58. Pharmacogenomics. 2009. PMID: 19663677 Review.
Cited by
-
The role of vitamin D in male fertility: A focus on the testis.Rev Endocr Metab Disord. 2017 Sep;18(3):285-305. doi: 10.1007/s11154-017-9425-0. Rev Endocr Metab Disord. 2017. PMID: 28667465 Review.
-
FSH and bone: Comparison between males with central versus primary hypogonadism.Front Endocrinol (Lausanne). 2022 Aug 5;13:939897. doi: 10.3389/fendo.2022.939897. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35992104 Free PMC article.
-
Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men.Endocr Connect. 2021 Jul 14;10(7):758-766. doi: 10.1530/EC-21-0109. Endocr Connect. 2021. PMID: 34137730 Free PMC article.
-
Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action.Int J Endocrinol. 2015;2015:298107. doi: 10.1155/2015/298107. Epub 2015 Sep 2. Int J Endocrinol. 2015. PMID: 26421011 Free PMC article. Review.
-
Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology.J Endocrinol Invest. 2015 Jan;38(1):103-12. doi: 10.1007/s40618-014-0155-9. Epub 2014 Nov 11. J Endocrinol Invest. 2015. PMID: 25384570 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous